LENSAR, Inc. (LNSR)

Market Cap	89.43M
Revenue (ttm)	48.87M
Net Income (ttm)	-16.63M
Shares Out	11.61M
EPS (ttm)	-1.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,047
Open	7.46
Previous Close	7.50
Day's Range	7.41 - 7.88
52-Week Range	2.67 - 8.17
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 130
• Stock Exchange: NASDAQ
• Ticker Symbol: LNSR
• Website: https://www.lensar.com

Financial Performance

In 2023, LENSAR's revenue was $42.16 million, an increase of 19.25% compared to the previous year's $35.36 million. Losses were -$14.38 million, -27.77% less than in 2022.